nodes	percent_of_prediction	percent_of_DWPC	metapath
Lisuride—ADRB1—dilated cardiomyopathy	0.772	1	CbGaD
Lisuride—HTR2B—cardial valve—dilated cardiomyopathy	0.02	0.452	CbGeAlD
Lisuride—HTR2A—pulmonary artery—dilated cardiomyopathy	0.00432	0.0977	CbGeAlD
Lisuride—HTR2A—sympathetic nervous system—dilated cardiomyopathy	0.0042	0.095	CbGeAlD
Lisuride—DRD4—heart—dilated cardiomyopathy	0.00301	0.068	CbGeAlD
Lisuride—Cabergoline—ADRB1—dilated cardiomyopathy	0.00254	0.543	CrCbGaD
Lisuride—Cabergoline—ADRB2—dilated cardiomyopathy	0.00214	0.457	CrCbGaD
Lisuride—ADRB1—cardiac ventricle—dilated cardiomyopathy	0.00176	0.0397	CbGeAlD
Lisuride—ADRB1—myocardium—dilated cardiomyopathy	0.00165	0.0374	CbGeAlD
Lisuride—ADRA2C—cardiac ventricle—dilated cardiomyopathy	0.00132	0.0299	CbGeAlD
Lisuride—ADRA2C—myocardium—dilated cardiomyopathy	0.00125	0.0282	CbGeAlD
Lisuride—ADRB1—heart—dilated cardiomyopathy	0.00115	0.0261	CbGeAlD
Lisuride—Pleural effusion—Lisinopril—dilated cardiomyopathy	0.00111	0.0422	CcSEcCtD
Lisuride—HTR2B—heart—dilated cardiomyopathy	0.0011	0.025	CbGeAlD
Lisuride—ADRB1—cardiac atrium—dilated cardiomyopathy	0.000987	0.0223	CbGeAlD
Lisuride—ADRA2C—heart—dilated cardiomyopathy	0.000869	0.0197	CbGeAlD
Lisuride—Dehydration—Furosemide—dilated cardiomyopathy	0.000768	0.0291	CcSEcCtD
Lisuride—Orthostatic hypotension—Furosemide—dilated cardiomyopathy	0.000754	0.0285	CcSEcCtD
Lisuride—Confusional state—Spironolactone—dilated cardiomyopathy	0.000752	0.0285	CcSEcCtD
Lisuride—ADRA2C—cardiac atrium—dilated cardiomyopathy	0.000743	0.0168	CbGeAlD
Lisuride—ADRA2A—heart—dilated cardiomyopathy	0.000694	0.0157	CbGeAlD
Lisuride—Somnolence—Spironolactone—dilated cardiomyopathy	0.000663	0.0251	CcSEcCtD
Lisuride—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.000644	0.0244	CcSEcCtD
Lisuride—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.000615	0.0233	CcSEcCtD
Lisuride—Disturbance in sexual arousal—Lisinopril—dilated cardiomyopathy	0.000615	0.0233	CcSEcCtD
Lisuride—Sweating—Furosemide—dilated cardiomyopathy	0.00061	0.0231	CcSEcCtD
Lisuride—ADRA2A—cardiac atrium—dilated cardiomyopathy	0.000593	0.0134	CbGeAlD
Lisuride—HTR2A—heart—dilated cardiomyopathy	0.00059	0.0133	CbGeAlD
Lisuride—Dehydration—Lisinopril—dilated cardiomyopathy	0.000576	0.0218	CcSEcCtD
Lisuride—Orthostatic hypotension—Lisinopril—dilated cardiomyopathy	0.000566	0.0214	CcSEcCtD
Lisuride—Angiopathy—Furosemide—dilated cardiomyopathy	0.000518	0.0196	CcSEcCtD
Lisuride—Immune system disorder—Furosemide—dilated cardiomyopathy	0.000516	0.0195	CcSEcCtD
Lisuride—Malnutrition—Furosemide—dilated cardiomyopathy	0.000497	0.0188	CcSEcCtD
Lisuride—Dizziness—Spironolactone—dilated cardiomyopathy	0.000493	0.0187	CcSEcCtD
Lisuride—Weight increased—Lisinopril—dilated cardiomyopathy	0.000487	0.0184	CcSEcCtD
Lisuride—Weight decreased—Lisinopril—dilated cardiomyopathy	0.000484	0.0183	CcSEcCtD
Lisuride—Vomiting—Spironolactone—dilated cardiomyopathy	0.000474	0.0179	CcSEcCtD
Lisuride—Headache—Spironolactone—dilated cardiomyopathy	0.000467	0.0177	CcSEcCtD
Lisuride—Sweating—Lisinopril—dilated cardiomyopathy	0.000458	0.0173	CcSEcCtD
Lisuride—Vertigo—Furosemide—dilated cardiomyopathy	0.000447	0.0169	CcSEcCtD
Lisuride—Hallucination—Lisinopril—dilated cardiomyopathy	0.000426	0.0161	CcSEcCtD
Lisuride—Oedema peripheral—Lisinopril—dilated cardiomyopathy	0.000422	0.016	CcSEcCtD
Lisuride—Dry mouth—Furosemide—dilated cardiomyopathy	0.000414	0.0157	CcSEcCtD
Lisuride—Confusional state—Furosemide—dilated cardiomyopathy	0.000409	0.0155	CcSEcCtD
Lisuride—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.000398	0.0151	CcSEcCtD
Lisuride—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.000392	0.0148	CcSEcCtD
Lisuride—Angiopathy—Lisinopril—dilated cardiomyopathy	0.000389	0.0147	CcSEcCtD
Lisuride—Anorexia—Furosemide—dilated cardiomyopathy	0.000387	0.0146	CcSEcCtD
Lisuride—Mediastinal disorder—Lisinopril—dilated cardiomyopathy	0.000386	0.0146	CcSEcCtD
Lisuride—Mental disorder—Lisinopril—dilated cardiomyopathy	0.000375	0.0142	CcSEcCtD
Lisuride—Malnutrition—Lisinopril—dilated cardiomyopathy	0.000373	0.0141	CcSEcCtD
Lisuride—Somnolence—Furosemide—dilated cardiomyopathy	0.000361	0.0137	CcSEcCtD
Lisuride—Decreased appetite—Furosemide—dilated cardiomyopathy	0.000353	0.0133	CcSEcCtD
Lisuride—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.00035	0.0133	CcSEcCtD
Lisuride—Fatigue—Furosemide—dilated cardiomyopathy	0.00035	0.0132	CcSEcCtD
Lisuride—Constipation—Furosemide—dilated cardiomyopathy	0.000347	0.0131	CcSEcCtD
Lisuride—Vertigo—Lisinopril—dilated cardiomyopathy	0.000335	0.0127	CcSEcCtD
Lisuride—Syncope—Lisinopril—dilated cardiomyopathy	0.000335	0.0127	CcSEcCtD
Lisuride—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.000334	0.0127	CcSEcCtD
Lisuride—Palpitations—Lisinopril—dilated cardiomyopathy	0.00033	0.0125	CcSEcCtD
Lisuride—Cough—Lisinopril—dilated cardiomyopathy	0.000326	0.0123	CcSEcCtD
Lisuride—Anxiety—Lisinopril—dilated cardiomyopathy	0.000317	0.012	CcSEcCtD
Lisuride—Dry mouth—Lisinopril—dilated cardiomyopathy	0.000311	0.0118	CcSEcCtD
Lisuride—Confusional state—Lisinopril—dilated cardiomyopathy	0.000307	0.0116	CcSEcCtD
Lisuride—Infection—Lisinopril—dilated cardiomyopathy	0.000303	0.0114	CcSEcCtD
Lisuride—Tachycardia—Lisinopril—dilated cardiomyopathy	0.000297	0.0112	CcSEcCtD
Lisuride—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.000294	0.0111	CcSEcCtD
Lisuride—Asthenia—Furosemide—dilated cardiomyopathy	0.000291	0.011	CcSEcCtD
Lisuride—Anorexia—Lisinopril—dilated cardiomyopathy	0.00029	0.011	CcSEcCtD
Lisuride—Insomnia—Lisinopril—dilated cardiomyopathy	0.000275	0.0104	CcSEcCtD
Lisuride—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.000271	0.0103	CcSEcCtD
Lisuride—Somnolence—Lisinopril—dilated cardiomyopathy	0.000271	0.0102	CcSEcCtD
Lisuride—Dizziness—Furosemide—dilated cardiomyopathy	0.000268	0.0102	CcSEcCtD
Lisuride—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.000265	0.01	CcSEcCtD
Lisuride—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.000263	0.00995	CcSEcCtD
Lisuride—Fatigue—Lisinopril—dilated cardiomyopathy	0.000263	0.00993	CcSEcCtD
Lisuride—Constipation—Lisinopril—dilated cardiomyopathy	0.00026	0.00985	CcSEcCtD
Lisuride—Vomiting—Furosemide—dilated cardiomyopathy	0.000258	0.00976	CcSEcCtD
Lisuride—Headache—Furosemide—dilated cardiomyopathy	0.000254	0.00962	CcSEcCtD
Lisuride—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.000251	0.0095	CcSEcCtD
Lisuride—Asthenia—Lisinopril—dilated cardiomyopathy	0.000218	0.00827	CcSEcCtD
Lisuride—Dizziness—Lisinopril—dilated cardiomyopathy	0.000201	0.00762	CcSEcCtD
Lisuride—Vomiting—Lisinopril—dilated cardiomyopathy	0.000194	0.00733	CcSEcCtD
Lisuride—Headache—Lisinopril—dilated cardiomyopathy	0.000191	0.00722	CcSEcCtD
Lisuride—ADRA2C—Hemostasis—RAF1—dilated cardiomyopathy	3.13e-05	0.000204	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—ANKRD1—dilated cardiomyopathy	3.12e-05	0.000204	CbGpPWpGaD
Lisuride—ADRA2A—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	3.12e-05	0.000204	CbGpPWpGaD
Lisuride—HTR2A—Signaling by GPCR—ADRB2—dilated cardiomyopathy	3.11e-05	0.000203	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—CXCR3—dilated cardiomyopathy	3.11e-05	0.000203	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—CXCR3—dilated cardiomyopathy	3.11e-05	0.000203	CbGpPWpGaD
Lisuride—DRD1—Signaling by GPCR—AGT—dilated cardiomyopathy	3.11e-05	0.000203	CbGpPWpGaD
Lisuride—HTR1A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	3.08e-05	0.000201	CbGpPWpGaD
Lisuride—ADRB1—GPCR downstream signaling—AGT—dilated cardiomyopathy	3.08e-05	0.000201	CbGpPWpGaD
Lisuride—ADRA1D—Signaling by GPCR—AGT—dilated cardiomyopathy	3.07e-05	0.0002	CbGpPWpGaD
Lisuride—DRD3—Signaling by GPCR—AGT—dilated cardiomyopathy	3.07e-05	0.0002	CbGpPWpGaD
Lisuride—HTR2C—GPCR downstream signaling—RAC1—dilated cardiomyopathy	3.06e-05	0.0002	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—ADRB1—dilated cardiomyopathy	3.06e-05	0.0002	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—CXCL2—dilated cardiomyopathy	3.05e-05	0.000199	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—AGTR2—dilated cardiomyopathy	3.05e-05	0.000199	CbGpPWpGaD
Lisuride—ADRA2B—GPCR downstream signaling—AGT—dilated cardiomyopathy	3.05e-05	0.000199	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—CXCL2—dilated cardiomyopathy	3.02e-05	0.000197	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—AGTR2—dilated cardiomyopathy	3.02e-05	0.000197	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—ADRB1—dilated cardiomyopathy	3.01e-05	0.000197	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—ADRB1—dilated cardiomyopathy	3.01e-05	0.000197	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—AGTR1—dilated cardiomyopathy	3.01e-05	0.000196	CbGpPWpGaD
Lisuride—ADRA2A—Signaling by GPCR—AGTR1—dilated cardiomyopathy	2.99e-05	0.000195	CbGpPWpGaD
Lisuride—ADRA2C—GPCR downstream signaling—RAC1—dilated cardiomyopathy	2.98e-05	0.000195	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—AGTR1—dilated cardiomyopathy	2.95e-05	0.000192	CbGpPWpGaD
Lisuride—HTR1A—GPCR downstream signaling—AGT—dilated cardiomyopathy	2.94e-05	0.000192	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—TAZ—dilated cardiomyopathy	2.93e-05	0.000192	CbGpPWpGaD
Lisuride—ADRA1B—GPCR downstream signaling—RAC1—dilated cardiomyopathy	2.93e-05	0.000192	CbGpPWpGaD
Lisuride—HTR2C—GPCR downstream signaling—AGT—dilated cardiomyopathy	2.93e-05	0.000191	CbGpPWpGaD
Lisuride—ADRB1—Signaling by GPCR—RAC1—dilated cardiomyopathy	2.92e-05	0.000191	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—AGTR2—dilated cardiomyopathy	2.92e-05	0.000191	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—CXCL2—dilated cardiomyopathy	2.92e-05	0.000191	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—CXCL2—dilated cardiomyopathy	2.9e-05	0.00019	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—AGTR2—dilated cardiomyopathy	2.9e-05	0.00019	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—AGTR1—dilated cardiomyopathy	2.9e-05	0.000189	CbGpPWpGaD
Lisuride—ADRA2B—Signaling by GPCR—RAC1—dilated cardiomyopathy	2.9e-05	0.000189	CbGpPWpGaD
Lisuride—DRD5—Signaling Pathways—RAC1—dilated cardiomyopathy	2.89e-05	0.000189	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—PSEN2—dilated cardiomyopathy	2.89e-05	0.000188	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—ADRB2—dilated cardiomyopathy	2.85e-05	0.000186	CbGpPWpGaD
Lisuride—ADRA2C—GPCR downstream signaling—AGT—dilated cardiomyopathy	2.85e-05	0.000186	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—PSEN2—dilated cardiomyopathy	2.84e-05	0.000185	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—CXCR3—dilated cardiomyopathy	2.84e-05	0.000185	CbGpPWpGaD
Lisuride—ADRA2A—Signaling by GPCR—ADRB2—dilated cardiomyopathy	2.83e-05	0.000185	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—AGTR2—dilated cardiomyopathy	2.82e-05	0.000184	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—CXCL2—dilated cardiomyopathy	2.82e-05	0.000184	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—CXCR3—dilated cardiomyopathy	2.81e-05	0.000184	CbGpPWpGaD
Lisuride—ADRA1B—GPCR downstream signaling—AGT—dilated cardiomyopathy	2.8e-05	0.000183	CbGpPWpGaD
Lisuride—HTR1A—Signaling by GPCR—RAC1—dilated cardiomyopathy	2.8e-05	0.000183	CbGpPWpGaD
Lisuride—ADRB1—Signaling by GPCR—AGT—dilated cardiomyopathy	2.79e-05	0.000183	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—ADRB2—dilated cardiomyopathy	2.79e-05	0.000183	CbGpPWpGaD
Lisuride—HTR2C—Signaling by GPCR—RAC1—dilated cardiomyopathy	2.78e-05	0.000182	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—CXCL2—dilated cardiomyopathy	2.78e-05	0.000182	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—AGTR2—dilated cardiomyopathy	2.78e-05	0.000182	CbGpPWpGaD
Lisuride—ADRA2B—Signaling by GPCR—AGT—dilated cardiomyopathy	2.77e-05	0.000181	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—AGTR1—dilated cardiomyopathy	2.77e-05	0.000181	CbGpPWpGaD
Lisuride—DRD5—Signaling Pathways—AGT—dilated cardiomyopathy	2.76e-05	0.000181	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—ADRB2—dilated cardiomyopathy	2.75e-05	0.00018	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—ADRB1—dilated cardiomyopathy	2.72e-05	0.000178	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—CXCR3—dilated cardiomyopathy	2.71e-05	0.000177	CbGpPWpGaD
Lisuride—ADRA2C—Signaling by GPCR—RAC1—dilated cardiomyopathy	2.71e-05	0.000177	CbGpPWpGaD
Lisuride—DRD2—GPCR downstream signaling—RAC1—dilated cardiomyopathy	2.7e-05	0.000177	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—CXCR3—dilated cardiomyopathy	2.7e-05	0.000176	CbGpPWpGaD
Lisuride—HTR1A—Signaling by GPCR—AGT—dilated cardiomyopathy	2.67e-05	0.000175	CbGpPWpGaD
Lisuride—ADRA1B—Signaling by GPCR—RAC1—dilated cardiomyopathy	2.66e-05	0.000174	CbGpPWpGaD
Lisuride—HTR2A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	2.66e-05	0.000174	CbGpPWpGaD
Lisuride—HTR2C—Signaling by GPCR—AGT—dilated cardiomyopathy	2.66e-05	0.000174	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	2.65e-05	0.000173	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—ADRB1—dilated cardiomyopathy	2.63e-05	0.000172	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—ADRB2—dilated cardiomyopathy	2.62e-05	0.000171	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—CXCR3—dilated cardiomyopathy	2.62e-05	0.000171	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—ADRB1—dilated cardiomyopathy	2.61e-05	0.000171	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—AGTR1—dilated cardiomyopathy	2.61e-05	0.00017	CbGpPWpGaD
Lisuride—ADRA2C—Signaling by GPCR—AGT—dilated cardiomyopathy	2.59e-05	0.000169	CbGpPWpGaD
Lisuride—DRD2—GPCR downstream signaling—AGT—dilated cardiomyopathy	2.58e-05	0.000169	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—CXCR3—dilated cardiomyopathy	2.58e-05	0.000169	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—PSEN2—dilated cardiomyopathy	2.58e-05	0.000169	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—AGTR1—dilated cardiomyopathy	2.57e-05	0.000168	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—AGTR1—dilated cardiomyopathy	2.57e-05	0.000168	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—CXCL2—dilated cardiomyopathy	2.56e-05	0.000167	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—AGTR2—dilated cardiomyopathy	2.56e-05	0.000167	CbGpPWpGaD
Lisuride—ADRA1B—Signaling by GPCR—AGT—dilated cardiomyopathy	2.55e-05	0.000166	CbGpPWpGaD
Lisuride—HTR2A—GPCR downstream signaling—AGT—dilated cardiomyopathy	2.54e-05	0.000166	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—ADRB1—dilated cardiomyopathy	2.54e-05	0.000166	CbGpPWpGaD
Lisuride—ADRA2A—Hemostasis—RAF1—dilated cardiomyopathy	2.54e-05	0.000166	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—AGTR2—dilated cardiomyopathy	2.52e-05	0.000165	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—CXCL2—dilated cardiomyopathy	2.52e-05	0.000165	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—ADRB1—dilated cardiomyopathy	2.5e-05	0.000163	CbGpPWpGaD
Lisuride—HTR1D—Signaling by GPCR—RAF1—dilated cardiomyopathy	2.49e-05	0.000162	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—ADRB2—dilated cardiomyopathy	2.48e-05	0.000162	CbGpPWpGaD
Lisuride—DRD2—Signaling by GPCR—RAC1—dilated cardiomyopathy	2.46e-05	0.00016	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	2.45e-05	0.00016	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—ADRB2—dilated cardiomyopathy	2.44e-05	0.00016	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—ADRB2—dilated cardiomyopathy	2.44e-05	0.00016	CbGpPWpGaD
Lisuride—HTR1B—Signaling by GPCR—RAF1—dilated cardiomyopathy	2.43e-05	0.000159	CbGpPWpGaD
Lisuride—ADRA2A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	2.42e-05	0.000158	CbGpPWpGaD
Lisuride—HTR2A—Signaling by GPCR—RAC1—dilated cardiomyopathy	2.42e-05	0.000158	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	2.4e-05	0.000157	CbGpPWpGaD
Lisuride—DRD4—Signaling by GPCR—RAF1—dilated cardiomyopathy	2.4e-05	0.000157	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—CXCR3—dilated cardiomyopathy	2.38e-05	0.000156	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	2.36e-05	0.000154	CbGpPWpGaD
Lisuride—DRD2—Signaling by GPCR—AGT—dilated cardiomyopathy	2.35e-05	0.000153	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—AGTR1—dilated cardiomyopathy	2.35e-05	0.000153	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—CXCR3—dilated cardiomyopathy	2.34e-05	0.000153	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—AGTR1—dilated cardiomyopathy	2.32e-05	0.000152	CbGpPWpGaD
Lisuride—ADRA2A—GPCR downstream signaling—AGT—dilated cardiomyopathy	2.31e-05	0.000151	CbGpPWpGaD
Lisuride—HTR2A—Signaling by GPCR—AGT—dilated cardiomyopathy	2.31e-05	0.000151	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—ADRB1—dilated cardiomyopathy	2.31e-05	0.000151	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—AGTR2—dilated cardiomyopathy	2.29e-05	0.00015	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—CXCL2—dilated cardiomyopathy	2.29e-05	0.00015	CbGpPWpGaD
Lisuride—HTR2B—Signaling by GPCR—RAF1—dilated cardiomyopathy	2.29e-05	0.000149	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—ADRB1—dilated cardiomyopathy	2.27e-05	0.000148	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	2.26e-05	0.000147	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—AGTR1—dilated cardiomyopathy	2.24e-05	0.000147	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—AGTR1—dilated cardiomyopathy	2.23e-05	0.000146	CbGpPWpGaD
Lisuride—DRD5—Signaling by GPCR—EGFR—dilated cardiomyopathy	2.23e-05	0.000145	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—ADRB2—dilated cardiomyopathy	2.23e-05	0.000145	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—RAC1—dilated cardiomyopathy	2.22e-05	0.000145	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—ADRB2—dilated cardiomyopathy	2.2e-05	0.000144	CbGpPWpGaD
Lisuride—ADRA2A—Signaling by GPCR—RAC1—dilated cardiomyopathy	2.2e-05	0.000144	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—AGTR1—dilated cardiomyopathy	2.17e-05	0.000142	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—RAC1—dilated cardiomyopathy	2.17e-05	0.000142	CbGpPWpGaD
Lisuride—DRD1—Signaling by GPCR—RAF1—dilated cardiomyopathy	2.16e-05	0.000141	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—AGTR1—dilated cardiomyopathy	2.14e-05	0.00014	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—RAC1—dilated cardiomyopathy	2.13e-05	0.000139	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—CXCR3—dilated cardiomyopathy	2.13e-05	0.000139	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—ADRB2—dilated cardiomyopathy	2.13e-05	0.000139	CbGpPWpGaD
Lisuride—DRD3—Signaling by GPCR—RAF1—dilated cardiomyopathy	2.13e-05	0.000139	CbGpPWpGaD
Lisuride—ADRA1D—Signaling by GPCR—RAF1—dilated cardiomyopathy	2.13e-05	0.000139	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	2.13e-05	0.000139	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—ADRB2—dilated cardiomyopathy	2.12e-05	0.000138	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—AGT—dilated cardiomyopathy	2.12e-05	0.000138	CbGpPWpGaD
Lisuride—ADRA2A—Signaling by GPCR—AGT—dilated cardiomyopathy	2.1e-05	0.000137	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	2.1e-05	0.000137	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	2.1e-05	0.000137	CbGpPWpGaD
Lisuride—ADRA2C—Metabolism—GPX1—dilated cardiomyopathy	2.08e-05	0.000136	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—AGT—dilated cardiomyopathy	2.07e-05	0.000135	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—ADRB1—dilated cardiomyopathy	2.06e-05	0.000135	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—ADRB2—dilated cardiomyopathy	2.06e-05	0.000135	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—AGT—dilated cardiomyopathy	2.04e-05	0.000133	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—RAC1—dilated cardiomyopathy	2.04e-05	0.000133	CbGpPWpGaD
Lisuride—ADRA2C—Metabolism—CD36—dilated cardiomyopathy	2.03e-05	0.000133	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—ADRB2—dilated cardiomyopathy	2.03e-05	0.000132	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.97e-05	0.000129	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—AGT—dilated cardiomyopathy	1.95e-05	0.000127	CbGpPWpGaD
Lisuride—ADRB1—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.94e-05	0.000127	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.94e-05	0.000127	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—RAC1—dilated cardiomyopathy	1.92e-05	0.000126	CbGpPWpGaD
Lisuride—ADRA2B—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.92e-05	0.000126	CbGpPWpGaD
Lisuride—DRD5—Signaling Pathways—RAF1—dilated cardiomyopathy	1.92e-05	0.000125	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.91e-05	0.000125	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—RAC1—dilated cardiomyopathy	1.9e-05	0.000124	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—RAC1—dilated cardiomyopathy	1.9e-05	0.000124	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.89e-05	0.000124	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.87e-05	0.000122	CbGpPWpGaD
Lisuride—HTR1A—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.85e-05	0.000121	CbGpPWpGaD
Lisuride—HTR2C—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.85e-05	0.000121	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.84e-05	0.00012	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—AGT—dilated cardiomyopathy	1.84e-05	0.00012	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.83e-05	0.000119	CbGpPWpGaD
Lisuride—ADRA2C—Metabolism—AGT—dilated cardiomyopathy	1.83e-05	0.000119	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.82e-05	0.000119	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—AGT—dilated cardiomyopathy	1.81e-05	0.000118	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—AGT—dilated cardiomyopathy	1.81e-05	0.000118	CbGpPWpGaD
Lisuride—ADRA2C—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.79e-05	0.000117	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.77e-05	0.000116	CbGpPWpGaD
Lisuride—ADRA1B—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.77e-05	0.000115	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.76e-05	0.000115	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.74e-05	0.000114	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—RAC1—dilated cardiomyopathy	1.73e-05	0.000113	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—RAC1—dilated cardiomyopathy	1.71e-05	0.000112	CbGpPWpGaD
Lisuride—HTR1D—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.71e-05	0.000111	CbGpPWpGaD
Lisuride—ADRA2A—Metabolism—GPX1—dilated cardiomyopathy	1.69e-05	0.000111	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.67e-05	0.000109	CbGpPWpGaD
Lisuride—HTR1B—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.67e-05	0.000109	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—RAC1—dilated cardiomyopathy	1.65e-05	0.000108	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—AGT—dilated cardiomyopathy	1.65e-05	0.000108	CbGpPWpGaD
Lisuride—ADRA2A—Metabolism—CD36—dilated cardiomyopathy	1.65e-05	0.000108	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—RAC1—dilated cardiomyopathy	1.64e-05	0.000107	CbGpPWpGaD
Lisuride—DRD4—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.64e-05	0.000107	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—AGT—dilated cardiomyopathy	1.64e-05	0.000107	CbGpPWpGaD
Lisuride—DRD2—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.63e-05	0.000106	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.61e-05	0.000105	CbGpPWpGaD
Lisuride—HTR2A—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.6e-05	0.000105	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—RAC1—dilated cardiomyopathy	1.6e-05	0.000104	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.58e-05	0.000103	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—AGT—dilated cardiomyopathy	1.58e-05	0.000103	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—RAC1—dilated cardiomyopathy	1.57e-05	0.000103	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—AGT—dilated cardiomyopathy	1.57e-05	0.000103	CbGpPWpGaD
Lisuride—HTR2B—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.57e-05	0.000102	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—AGT—dilated cardiomyopathy	1.53e-05	9.98e-05	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—AGT—dilated cardiomyopathy	1.5e-05	9.82e-05	CbGpPWpGaD
Lisuride—ADRA2A—Metabolism—AGT—dilated cardiomyopathy	1.48e-05	9.69e-05	CbGpPWpGaD
Lisuride—DRD1—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.48e-05	9.66e-05	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—RAF1—dilated cardiomyopathy	1.47e-05	9.6e-05	CbGpPWpGaD
Lisuride—DRD3—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.46e-05	9.53e-05	CbGpPWpGaD
Lisuride—ADRA1D—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.46e-05	9.53e-05	CbGpPWpGaD
Lisuride—ADRA2A—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.46e-05	9.52e-05	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—RAC1—dilated cardiomyopathy	1.45e-05	9.48e-05	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—RAF1—dilated cardiomyopathy	1.44e-05	9.4e-05	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.44e-05	9.39e-05	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—RAC1—dilated cardiomyopathy	1.43e-05	9.33e-05	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—RAF1—dilated cardiomyopathy	1.42e-05	9.25e-05	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—AGT—dilated cardiomyopathy	1.39e-05	9.06e-05	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—AGT—dilated cardiomyopathy	1.36e-05	8.91e-05	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—RAF1—dilated cardiomyopathy	1.35e-05	8.83e-05	CbGpPWpGaD
Lisuride—ADRB1—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.33e-05	8.69e-05	CbGpPWpGaD
Lisuride—ADRA2B—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.32e-05	8.61e-05	CbGpPWpGaD
Lisuride—DRD5—Signaling Pathways—EGFR—dilated cardiomyopathy	1.32e-05	8.59e-05	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—RAC1—dilated cardiomyopathy	1.3e-05	8.48e-05	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—RAF1—dilated cardiomyopathy	1.27e-05	8.32e-05	CbGpPWpGaD
Lisuride—HTR1A—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.27e-05	8.31e-05	CbGpPWpGaD
Lisuride—HTR2C—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.27e-05	8.27e-05	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—RAF1—dilated cardiomyopathy	1.26e-05	8.21e-05	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—RAF1—dilated cardiomyopathy	1.26e-05	8.21e-05	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—AGT—dilated cardiomyopathy	1.24e-05	8.11e-05	CbGpPWpGaD
Lisuride—ADRA2C—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.23e-05	8.04e-05	CbGpPWpGaD
Lisuride—ADRA1B—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.21e-05	7.91e-05	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—RAF1—dilated cardiomyopathy	1.15e-05	7.48e-05	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—RAF1—dilated cardiomyopathy	1.14e-05	7.41e-05	CbGpPWpGaD
Lisuride—DRD2—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.12e-05	7.3e-05	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—GPX1—dilated cardiomyopathy	1.1e-05	7.2e-05	CbGpPWpGaD
Lisuride—HTR2A—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.1e-05	7.18e-05	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—RAF1—dilated cardiomyopathy	1.1e-05	7.16e-05	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—RAF1—dilated cardiomyopathy	1.09e-05	7.12e-05	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—CD36—dilated cardiomyopathy	1.07e-05	7.02e-05	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—RAF1—dilated cardiomyopathy	1.06e-05	6.93e-05	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—RAF1—dilated cardiomyopathy	1.04e-05	6.82e-05	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—EGFR—dilated cardiomyopathy	1.01e-05	6.58e-05	CbGpPWpGaD
Lisuride—ADRA2A—Signaling by GPCR—EGFR—dilated cardiomyopathy	1e-05	6.53e-05	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—EGFR—dilated cardiomyopathy	9.86e-06	6.44e-05	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—EGFR—dilated cardiomyopathy	9.71e-06	6.34e-05	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—AGT—dilated cardiomyopathy	9.67e-06	6.32e-05	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—RAF1—dilated cardiomyopathy	9.62e-06	6.28e-05	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—RAF1—dilated cardiomyopathy	9.47e-06	6.18e-05	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—EGFR—dilated cardiomyopathy	9.27e-06	6.05e-05	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—EGFR—dilated cardiomyopathy	8.74e-06	5.71e-05	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—EGFR—dilated cardiomyopathy	8.62e-06	5.63e-05	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—EGFR—dilated cardiomyopathy	8.62e-06	5.63e-05	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—RAF1—dilated cardiomyopathy	8.61e-06	5.63e-05	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—EGFR—dilated cardiomyopathy	7.86e-06	5.13e-05	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—EGFR—dilated cardiomyopathy	7.78e-06	5.08e-05	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—EGFR—dilated cardiomyopathy	7.51e-06	4.91e-05	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—EGFR—dilated cardiomyopathy	7.48e-06	4.88e-05	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—EGFR—dilated cardiomyopathy	7.27e-06	4.75e-05	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	7.21e-06	4.71e-05	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—EGFR—dilated cardiomyopathy	7.16e-06	4.67e-05	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	7.02e-06	4.59e-05	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—EGFR—dilated cardiomyopathy	6.6e-06	4.31e-05	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—EGFR—dilated cardiomyopathy	6.49e-06	4.24e-05	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	6.32e-06	4.13e-05	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—EGFR—dilated cardiomyopathy	5.91e-06	3.86e-05	CbGpPWpGaD
